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Increased production of tumor necrosis factor (TNF)-
and matrix metalloproteinases (MMPs) is a feature of
inflammatory lung diseases, including emphysema and
fibrosis, but the divergent pathological characteristics
that result indicate involvement of other processes in
disease pathogenesis. Transgenic mice overexpressing
TNF- in type II alveolar epithelial cells under the con-
trol of the surfactant protein (SP)-C promoter develop
pulmonary inflammation and emphysema but are re-
sistant to induction of fibrosis by administration of
bleomycin or transforming growth factor-. To study
the molecular mechanisms underlying the develop-
ment of this phenotype, we used amicroarray approach
to characterize the pulmonary transcriptome of SP-C/
TNF- mice and wild-type littermates. Four-month-old
SP-C/TNF-mice displayed pronounced pulmonary in-
flammation, airspace enlargement, increased MMP-2
and MMP-9 levels, and altered expression of 2332
probes. The functional assessment of genes with in-
creased expression revealed enrichment of inflamma-
tory/immune responses and proteases, whereas genes
involved in protease inhibition, angiogenesis, cross-
linking of basementmembrane proteins, andmyofibro-
blast differentiation were predominantly decreased.
Comparison with multiple lung disease models identi-
fied a set of genes unique to the SP-C/TNF-model and
revealed that lack of extracellular matrix production
distinguished SP-C/TNF- mice from fibrosis models.
Activation of inflammatory and proteolytic pathways
and disruption ofmaintenance and repair processes are
central features of emphysema in this TNF-overexpres-
sion model. Impairment of myofibroblast differentia-
tion and extracellular matrix production may underlieresistance to induction of fibrosis. (Am J Pathol 2012,
180:1413–1430; DOI: 10.1016/j.ajpath.2011.12.020)
The pulmonary immune system protects the lungs from
the harmful effects of inhaled xenobiotics and pathogens,
in part through the release of pro-inflammatory mediators.
These mediators activate professional phagocytes that
work to clear the lungs of contaminating material. Al-
though transient activation of the inflammatory system
can be effective in responding to immune challenges in
the lungs without causing lasting injury, chronic inflamma-
tory processes can contribute to destruction of lung archi-
tecture, even after elimination of the noxious agent, ulti-
mately leading to pathological conditions, such as
emphysema. For example, increased levels of macro-
phages and neutrophils persist in the lungs of former smok-
ers with chronic obstructive pulmonary disorder, even after
smoking cessation, resulting in sustained increases in the
production of proteolytic enzymes.1 Although an imbalance
of proteases and protease inhibitors is thought to be a
primary cause of the substantial remodeling and destruc-
tion of alveolar walls that occur in emphysema,2 other pro-
cesses, including apoptosis,3 cellular senescence,4 and
dysfunctional repair systems,3,5 have also been postulated
to play a role. It is clear that several interrelated cellular and
molecular events contribute to pathological conditions re-
sulting from a chronic inflammatory state in the lungs.6 Un-
derstanding how diverse factors contribute collectively to
the development of lung pathological conditions remains an
active area of research.
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and compared are useful to gain a better understanding
of processes underlying pulmonary diseases and to
characterize the role of specific agents in disease patho-
genesis.7 Tumor necrosis factor (TNF)- is a pleiotropic
cytokine implicated in several lung pathological condi-
tions, including fibrosis, emphysema, asthma, and con-
nective tissue breakdown associated with cigarette
smoking.8–10 To evaluate the involvement of TNF- in
inflammatory lung disease, transgenic mice that consti-
tutively express TNF- in alveolar type II epithelial cells
under the control of the surfactant protein (SP)-C pro-
moter were generated.11 These mice develop chronic
inflammation and airspace enlargement.11,12 On the ba-
sis of the interstitial inflammation and increased collagen
deposition, SP-C/TNF- mice were initially characterized
as a model of idiopathic pulmonary fibrosis.11 However,
subsequent work by Fujita et al12 demonstrated that the
transgenic mice were characterized by large lung vol-
umes and decreased elastic recoil, a phenotype more
similar to emphysema. Moreover, although hydroxypro-
line content was increased per lung, there was no in-
crease when values were normalized to lung weight, sug-
gesting that the effect was related to an increase in the
size of the lungs, rather than to fibrosis.12 Physiological
and morphometric imaging analyses confirmed that this
model displayed features of emphysema, also revealing
some consolidation of airspaces consistent with fibro-
sis.13 Remarkably, although TNF- has been impli-
cated in the pathogenesis of fibrosis in humans,14,15
and anti–TNF- antibodies attenuate bleomycin- or sil-
ica-induced fibrosis in animals,10,16 the lungs of SP-C/
TNF- mice are resistant to initiation of fibrosis by
instillation of transforming growth factor (TGF)- or
bleomycin.17 Together, the data suggest that factors
other than TNF- alone are important in determining
the fate of injured lungs.
Given the pleiotropic nature of TNF- signaling and its
association with several lung pathological conditions with
differing phenotypes, an understanding of the molecular
pathways modulated by TNF- expression in the lungs
should be of use in characterizing disease pathogenesis
and identifying potential therapeutic targets for further
investigation. Global screening approaches offer power-
ful tools to assess biological pathways that drive disease
phenotypes.7 To gain a better understanding of the mo-
lecular processes underlying the chronic inflammatory
state and resistance to induction of fibrosis of the SP-C/
TNF- mice, in the present study, we used a microarray
approach to compare the level of expression of approx-
imately 21,000 genes in the lungs of TNF-overexpressing
mice and wild-type littermates. We then contrasted the
SP-C/TNF- lung transcriptome with 12 other models of
lung disease to identify key molecular pathways that dis-
tinguish disease phenotypes. We report that constitutive
expression of TNF- in the lungs results in several effects
on critical pathways implicated in the pathogenesis of
emphysema, including increased expression of genes
involved in inflammation and matrix remodeling and re-
duced expression of genes involved in lung repair, main-
tenance pathways, and myofibroblast differentiation.Materials and Methods
Animals
SP-C/TNF- male mice (C57BL/6 background)11 were
originally provided by Dr. Robert Mason (National Jewish
Medical and Research Center, Denver, CO). The SP-C/
TNF- male mice were crossed with C57BL/6 female
mice (Charles River Laboratories, St. Constant, QC, Can-
ada) and maintained as a heterozygous line by repeated
backcrossing. Male transgenic mice and their wild-type
littermates were genotyped by PCR analysis of genomic
DNA isolated from ear punches, as previously de-
scribed.11 Animals were aged 132 5 days at the time of
the experiment. Mice were housed in individual Plexiglas
cages on wood-chip bedding under high-efficiency par-
ticulate filtered air and held to a 12-hour dark-light cycle.
Food and water were provided ad libitum. All experimen-
tal protocols were reviewed and approved by the Animal
Care Committee of Health Canada.
Biological Samples
Mice were anesthetized by administration of sodium pen-
tobarbital (60 mg/kg, i.p.). For histological examination,
lungs (n  3 per genotype) were inflated at 25 cm H2O
static pressure by intratracheal instillation of 4% parafor-
maldehyde in PBS. The lungs were excised, immersed in
fixative, and stored at 4°C. Tissue blocks were dehy-
drated in ethanol and embedded in paraffin. Sections
(0.75 m thick) were stained with H&E. For microarray
analyses, five mice per genotype were used, whereas for
real-time PCR analyses, lavage cytological examination,
and gelatin zymography, an independent set of four mice
per genotype were used. Lungs were washed by bron-
choalveolar lavage with saline (37°C) at 30 mL/kg body
weight, flash frozen in liquid nitrogen, and stored at
80°C. Lavage fluid was centrifuged (400  g for 10
minutes at 4°C) to remove cells and frozen at 80°C.
Cells were counted using a Coulter Multisizer II (Beck-
man Coulter Canada Inc., Mississauga, ON, Canada),
and differential cell counts were obtained from cytospin
preparations.
Gelatin Zymography
Bronchoalveolar lavage fluid from SP-C/TNF- and wild-
type mice was evaluated for matrix metalloproteinase
(MMP) activity by gelatin zymography. Equal quantities of
bronchoalveolar lavage fluid (20 L) were loaded on 10%
SDS-acrylamide gels containing 1 mg/mL gelatin (Sigma-
Aldrich Canada Ltd., Oakville, ON, Canada) and run for 1
hour at 200 mV. Each gel contained prestained mol. wt.
markers (Bio-Rad Laboratories Canada Ltd., Missis-
sauga, ON, Canada) and MMP-2 standards (Calbi-
ochem, La Jolla, CA). Gels were incubated in Zymogram
Renaturation Buffer (Bio-Rad Laboratories Canada Ltd.)
for 30 minutes, followed by overnight incubation at 37°C
in Zymogram Development Buffer (Bio-Rad Laboratories
Canada Ltd.). After incubation, gels were stained in 0.5%
Coomassie Blue R-250 (Sigma-Adrich Canada Ltd.)
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hour and then destained in a solution of 40% methanol/
10% acetic acid. Clear bands were assessed by densi-
tometric analysis using NIH shareware. To verify MMP
activity, control gels were incubated under the same con-
ditions in buffer containing 25 mmol/L EDTA.
RNA Isolation
Frozen lung samples were homogenized in TRIzol re-
agent (Invitrogen Canada Inc., Burlington, ON, Canada),
and total RNA was isolated according to the manufactur-
er’s instructions. The isolated RNA was further purified by
spin-column cleanup using RNeasy Mini Kits (Qiagen
Inc., Mississauga, ON, Canada). RNA was quantified us-
ing the RiboGreen RNA Quantitation Reagent and Kit
(Molecular Probes, Eugene, OR), and quality was con-
firmed using the RNA 6000 NanoLab Chip Kit (Agilent
Technologies Canada Inc., Mississauga, ON, Canada).
Microarray Analysis
Archived microarray data for age-matched transgenic
animals and wild-type littermates (n  5 per genotype)
from our inhalation facility18 were used for assessment of
the lung transcriptome. Microarray data are available at
the National Center for Biotechnology Information Gene
Expression Omnibus (accession no. GSE11037; http://
www.ncbi.nlm.nih.gov/projects/geo). Briefly, 2.5 g of
RNA was amplified and labeled using the Low RNA Input
Fluorescent Linear Amplification Kit (Agilent Technolo-
gies Canada Inc.), according to the manufacturer’s in-
structions. Agilent Mouse G4121A Microarrays were hy-
bridized with 5 g of Cy5-labeled lung RNA (one lung per
array). Cy3-labeled Universal Mouse Reference RNA
(Agilent Technologies Canada Inc.; 5 g) was used as a
common reference on all arrays. A randomized block
design was used for the order of sample hybridizations.
Arrays were scanned using a ScanArray Express scan-
ner (Perkin-Elmer Life Sciences, Woodbridge, ON, Can-
ada), and data were acquired with ImaGene 5.5 (BioDis-
covery, El Segundo, CA). Lowess normalization19 was
performed using SAS/STAT software, version 8.2 of the
SAS System for Windows (1999–2001; SAS Institute Inc.,
Cary, NC). The logarithm base 2 relative intensities were
used for subsequent analyses, and the MAANOVA li-
brary20 in R was used to identify differentially expressed
genes. The Fs statistic21 was used as a shrinkage esti-
mator for the gene-specific variance components, and P
values for all statistical tests were estimated using the
permutation method (1000 permutations with residual
shuffling). These P values were then adjusted for multiple
comparisons using the false-discovery rate (FDR) ap-
proach,22 and genes were considered differentially ex-
pressed if they had an FDR-adjusted P 0.05. The group
means for the fold-change calculation (transgenic versus
wild type) were based on the adjusted relative intensity
for each gene after subtraction of nuisance factors (eg,
day of hybridization) from the normalized ratio. Gene
ontology enrichment analysis and functional annotation
clustering were performed using the Database for Anno-tation, Visualization and Integrated Discovery23,24 (http://
david.abcc.ncifcrf.gov/home.jsp) using the array probe list
as the background population. Analysis of KEGG path-
ways (Kyoto Encyclopedia of Genes & Genomes online
resource, http://www.genome.ad.jp/kegg/pathway.html) was
also performed.
Comparison of Transcriptomes from Lung
Disease Models
Microarray data for 12 murine models of lung disease
were obtained from the National Center for Biotechnology
Information Gene Expression Omnibus site (accession
no. GSE4231; http://www.ncbi.nlm.nih.gov/projects/geo).
Because five different platforms were used in the analy-
ses, GenBank accession identification numbers were
used to identify probes common to all platforms. On
arrays that contained multiple probes for a given Gen-
Bank accession identification number, the lowess nor-
malized19 log2 of the ratios was averaged. Data were
then merged across the five platforms, yielding 7148
unique GenBank accession identification numbers. Dif-
ferentially expressed genes were identified as described
for the SP-C/TNF- arrays. Because of low power to
detect significant effects for several of the models, a less
stringent statistical filter of a 1.5-fold cutoff and an unad-
justed P  0.05 was used. Hierarchical clustering was
conducted using the top 50 genes with an unadjusted
P  0.05 ranked by fold change for each disease model,
excluding the SP-C/TNF- model. The distance metric
was one minus the Pearson correlation, and average
linkage was used.
Real-Time PCR
Real-time PCR was performed on samples used for mi-
croarray experiments (n  5 per genotype) or on inde-
pendent biological samples from age-matched animals
(n  4 per genotype). cDNA, 20 ng, was combined with
Quantitect (Qiagen Inc.) primer assays and real-time iQ
SYBR Green supermix (Bio-Rad Laboratories Canada
Ltd.), according to the product protocol, and run at an
annealing temperature of 55°C on the Lightcycler 480
(Roche Diagnostics, Laval, QC, Canada). Fluorescence
was monitored at every cycle during the 72°C elongation
step. Postrun melt curves were routinely inspected to
verify product purity. Expression was calculated relative
to the TATA-box binding protein, which exhibited un-
changed expression between genotypes (data not
shown), using the CT method. Statistical significance
was assessed by t-test (Sigma-Stat version 3.0; SPSS
Inc., Chicago, IL).
Results
SP-C/TNF- Mouse Lung Phenotype
Histological assessment of the inflated lungs confirmed
that SP-C/TNF- mice bred in our laboratory had en-
larged alveolar spaces and thickened septa compared
1416 Thomson et al
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pected.11,12 Increased cellularity was apparent in both
the alveoli and the interstitium. Bronchoalveolar lavage
recovered 10-fold higher numbers of cells in the trans-
genic mice compared with wild-type animals (Figure
1E), consisting of an eightfold increase in macro-
phages and increased numbers of neutrophils and
lymphocytes (Figure 1F).
Figure 2. Increased gelatinase activity in the lungs of SP-C/TNF- mice.
Gelatin zymography was performed on equal volumes of bronchoalveolar
lavage fluid recovered from wild-type (WT) and transgenic mice (n  4 per
genotype). A dilution series of MMP-2 standard was run alongside as a
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Figure 1. Lung phenotype of SP-C/TNF-mice. Lungs were inflated to 25 cm
H2O static pressure by intratracheal instillation of 4% paraformaldehyde in
PBS. Sections from the lungs of wild-type (A and C) and transgenic (B and D)
mice were stained with H&E. Original magnification: 40 (A and B); 100
(C andD). E: Total number of cells recovered in bronchoalveolar lavage fluid
(n  4 per genotype). F: Differential count of cells recovered by bronchoal-
veolar lavage (BAL; n  4 per genotype). *P  0.05, t-test. EOS, eosinophils;
LYM, lymphocytes; MAC, macrophages; M MAC, mature MAC; MNGC, multi-
nucleated giant cells; NEU, neutrophils; WT, wild type.positive control. Cleared areas (light bands) indicate gelatinase activity. stnd.,
standard.Levels of Gelatin-Degrading Enzymes
Because MMPs are implicated in basement membrane
remodeling and airspace enlargement, we examined
MMP levels in bronchoalveolar lavage fluid by gelatin
zymography. Clear bands representing areas of enzy-
matic activity were detected at 72 and 105 kDa in SP-C/
TNF- mice (Figure 2), corresponding to the expected
mol. wt. of pro-MMP-2 and pro-MMP-9, respectively,
whereas only a faint band at 72 kDa was observed in
wild-type animals. The enzyme activity was inhibited by
incubation of gels in buffer containing EDTA (data not
shown).
Differential Gene Expression
Comparison of the lung transcriptome of wild-type and
transgenic animals resulted in the identification of 2332
differentially expressed probes (FDR-adjusted P  0.05;
see Supplemental Table S1 at http://ajp.amjpathol.org).
Of the differentially expressed probes, 1283 (55%) were
increased and 1049 (45%) were decreased. Fold
changes ranged from 34-fold increased to sevenfold de-
creased expression relative to wild-type animals, with
most genes (67%) exhibiting a fold change of less than
two and 95% exhibiting a fold change of less than four
(summarized in Table 1). Cluster analysis performed on
unfiltered transcriptional profiles revealed a clear geno-
type effect, with samples from transgenic and wild-type
animals separated on two main branches (Figure 3A). To
generate a more conservative list of significant genes, a
twofold cutoff filter was applied to the list of significant
genes (Figure 3B). This filtering resulted in a list of 760
probes, of which 472 (62%) were increased and 288
(38%) were decreased. Probes with the greatest increase
in expression in the TNF lungs included Ig genes [eg,
Ig-joining chain, 34-fold; Ig  chain variable 38, 17-fold;
Ig heavy chain 1a (serum IgG2a), 16-fold; Ig  chain,
variable 1, 12-fold], consistent with the lymphocytic infil-
tration; the acute-phase response proteins serum amy-
loid A3 (30-fold) and serum amyloid A1 (10-fold); C-type
lectin domain family 4, member d (17-fold); and TNF-
(17-fold). Probes with the greatest decrease in expres-
sion included procollagen C-terminal enhancer protein
2a (sevenfold), a glycoprotein that potentiates collagen
cleavage; genes involved in biotransformation of endog-
Table 1. Fold-Change Distribution of Differentially Expressed
Probes (SP-C/TNF- versus Wild-Type) with FDR-
Adjusted P  0.05
Fold-change
range
Total
probes
Increased
expression
Decreased
expression
1–1.5 775 425 350
1.5–2 797 386 411
2–4 646 369 277
4–6 68 59 9
6–8 26 24 2
8–10 4 4 0
10 16 16 0enous and exogenous compounds, including cyto-
th fact
rum am
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AJP April 2012, Vol. 180, No. 4chrome P450, family 1, subfamily a, polypeptide 1 (six-
fold), sulfotransferase family 1D, member 1 (fivefold), and
flavin-containing monooxygenase 3 (fourfold); cyto-
chrome P450, family 2, subfamily s, polypeptide 1 (four-
fold); the scaffolding protein tetraspanin 7 (fivefold); in-
sulin-like growth factor binding proteins 2 (threefold) and
6 (threefold); and the tissue inhibitor of metalloprotei-
nase-3 (TIMP-3; threefold). Differential expression of a
panel of seven probes chosen to represent a range of
fold changes (threefold decrease to fivefold increase rel-
ative to wild type) was confirmed by real-time PCR (t-test,
P  0.05 for all genes; see Supplemental Figure S1 at
http://ajp.amjpathol.org). In general, the difference in
gene expression between genotypes was greater ac-
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Figure 3. Comparison of the lung transcriptome of wild-type (WT) and S
genotype) was hybridized to individual oligonucleotide arrays, scanned, and
set segregated samples according to genotype. Red indicates a high level
expression. The sample identities are indicated at the bottom of the conditi
by the two red lines) was applied, resulting in 760 probes passing this filt
chemokine (C-C motif) ligand; CNN, calponin; CTGF, connective tissue
monooxygenase; GSN, gelsolin; HEGFL, heparin-binding epidermal grow
RECK, reversion-inducing cysteine-rich protein with kazal motifs; SA, se
Table 2. Functional Enrichment of Terms Related to Cellular Loc
Term
Fold
enrichment
N
g
Extracellular region 1.8
Extracellular space 1.8
Extracellular region part 1.8
Cell surface 4.2
External side of the plasma membrane 5.1
Lysosome 4
Lytic vacuole 4
Vacuole 3.7
Plasma membrane 1.7
Membrane 1.2
Intrinsic to membrane 1.2
Integral to membrane 1.2
Plasma membrane part 1.6
MHC protein complex 6.3
Membrane part 1.2
Database for Annotation, Visualization and Integrated Discovery (DA
expressed genes (760 probes and 732 unique DAVID identification nu
background. Enriched terms with a Bonferroni-adjusted P  0.05 are displayed
MHC, major histocompatibility complex.cording to the PCR analysis than was observed in the
microarray data, as is common with microarray analyses,
but the direction of change was consistent.
Functional Analysis
Functional analysis was performed on the list of 760
probes with FDR-adjusted P  0.05 and a greater than
twofold difference in gene expression. Functional analy-
sis of terms related to cellular localization revealed that
the products of differentially expressed genes were pre-
dominantly associated with the extracellular space,
plasma membrane, or lysosome (Table 2). The most sig-
nificant enrichment of terms relating to molecular function
TNF-α
CTSZ
CCL20
14
CCL9
CCL8
A3 SAA1
CTSK
CTSS
MMP-9
MMP-12
GF-β
HEGFL
VEGF-D
ADN
FMO3
PCOLCE2
CYP1A1
CNN1
CYP2S1
SULT1D1
CTGF
VEGF-A
TIMP3
GSN
RECK
CTSB
CTSD
Wildtype – Average intensity (log2)
- mice. Cy5-labeled lung RNA from WT and transgenic mice (n  5 per
d as described in Materials and Methods. A: Clustering of the unfiltered data
ession relative to the reference RNA, whereas green indicates low relative
B: To generate a more conservative list, a twofold cutoff filter (indicated
vant non-Ig genes discussed in Results are identified. ADN, adipsin; CCL,
factor; CTS, cathepsin; CYP, cytochrome P450; FMO, flavin-containing
or-like growth factor; PCOLCE, procollagen C-endopeptidase enhancer;
yloid; SULT, sulfotransferase.
n
% of
total
Modified Fisher exact
P value
Bonferroni-adjusted
P value
23.2 4.4  1015 3.5  1012
21.0 9.6  1014 7.5  1011
21.9 1.2  1013 8.9  1011
5.1 4.5  1013 3.5  1010
3.8 3.7  1012 2.9  109
4.1 3.3  1010 2.5  107
4.1 3.3  1010 2.5  107
4.2 9.6  1010 7.4  107
17.1 2.4  109 1.8  106
44.4 3.5  106 2.7  103
34.3 1.2  105 9.1  103
34.2 1.3  105 1.0  102
12.3 1.5  105 1.1  102
1.4 1.9  105 1.5  102
37.0 2.4  105 1.9  102
nctional annotation analysis was performed using a list of differentially
with the Agilent mouse microarray G4121A probe list serving as theMMP-
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AJP April 2012, Vol. 180, No. 4was for chemokines, cytokines, and antigen binding
(Table 3), consistent with the pronounced inflammatory/
immune response. Functional analysis of biological pro-
cesses showed that the 472 genes with increased ex-
pression in the lungs of transgenic mice were strongly
enriched for terms related to immune system processes
and inflammation (Table 4). In contrast, the 288 genes
with decreased expression were enriched for terms re-
lating to blood vessel development and cytoskeletal or-
ganization and biogenesis (Table 5).
Functional annotation clustering of the gene ontology
termswas used to reduce redundancy across the functional
categories.24 Clustering of functional groups using medium
stringency resulted in 36 clusters, with a group geometric
mean of P  0.05, according to a modified Fisher’s exact
test (Table 6). Broadly speaking, the clusters containedgenes
involved in immune/inflammatory response (clusters 2, 12, 18,
and 19), Igs (clusters 4, 5, 8, and 15), cytokines/chemokines
(clusters 6, 14, and 36), membranes (clusters 7, 17, and 26),
carbohydrate binding (clusters 9 and 13), antigen processing
(cluster 10), cell differentiation/organ development (clusters
11, 20, and 27), proteases/peptidases and inhibitors (clusters
16 and 28), cell adhesion (cluster 21), phagocytosis (cluster
22), TNF (cluster 23), blood coagulation (cluster 24), oxi-
doreductase activity (cluster 25), angiogenesis (cluster 29),
leukocyte migration (cluster 30), cell proliferation (cluster 31),
and SH2 domain (cluster 32).
KEGG Pathway Analysis
Further functional analysis was performed by scanning all
KEGG pathways for involvement of genes differentially
expressed in the TNF model. Sorting by number of genes
with fold change 1.5-fold, top KEGG pathway hits in-
cluded cytokine-cytokine receptor interaction (60 genes;
26% of the pathway), cell adhesion molecules (49 genes;
31% of the pathway), regulation of actin cytoskeleton (36
genes; 17% of the pathway), and hematopoietic cell lin-
eage (34 genes; 39% of the pathway), consistent with the
functional analysis performed using gene ontology terms.
Pathways with the highest ratio of genes with increased
expression to genes with decreased expression included
several immune and inflammatory pathways, such as B-
cell receptor signaling (27 increased and 4 decreased),
antigen processing and presentation (24 increased and 0
Table 3. Functional Analysis of Molecular Function
Term
Fold
enrichment
No
ge
Chemokine activity 10.6
Chemokine receptor binding 10.4
Antigen binding 11
G-protein–coupled receptor binding 6.5
Carbohydrate binding 2.9
Cytokine activity 3
Receptor binding 2
Database for Annotation, Visualization and Integrated Discovery (DA
expressed genes (760 probes and 732 unique DAVID identification nu
background. Enriched terms with a Bonferroni-adjusted P  0.05 are disdecreased), T-cell receptor signaling pathway (23 in-creased and 4 decreased), Toll-like receptor signaling
pathway (20 increased and 2 decreased), asthma (16
increased and 0 decreased), cell cycle (10 increased
and 2 decreased), and apoptosis (9 increased and 1
decreased). Pathways with many genes with decreased
expression included tight junction (3 increased and 25
decreased), drug metabolism/cytochrome P450 (0 in-
creased and 20 decreased), glutathione metabolism (1
increased and 12 decreased), retinol metabolism (1 in-
creased and 10 decreased), and hedgehog signaling
pathway (1 increased and 7 decreased). Searchable
heat maps of all KEGG pathways are provided (see Sup-
plemental Appendix S1 at http://ajp.amjpathol.org).
Expression of Immune and Inflammatory
Mediators
To further investigate the enrichment of immune and in-
flammatory genes, we examined differential expression
of probes associated with the functional term inflamma-
tory response. Comparison of expression by heat map
display revealed that all but one gene exhibited higher
levels of expression in transgenic mice (Figure 4A). In
addition to TNF-, the list included TNF receptor super-
family member 4, pyrin, the acute-phase response pro-
teins serum amyloid A1 and A3, 12 chemokines, toll-like
receptor-2, and several complement factors and Ig
genes. Adipsin (complement factor D), a serine protease
first characterized as being down-regulated in adi-
pocytes by TNF-,25 was the only gene on the list with
decreased expression. To independently validate ob-
served differences in gene expression, we measured
transcript levels in a new set of age-matched animals
(n  4 per genotype) not used for the microarray ex-
periment. Real-time PCR confirmed a dramatic in-
crease in TNF- mRNA in SP-C/TNF- animals, as
expected, and increased expression of serum amyloid
A3, the chemokine (CXC) motif ligand 13, IL-4, and
lymphotoxin A (Figure 4B).
Expression of Proteases and Inhibitors
Given the pronounced airspace enlargement character-
istic of this model, we examined alteration of probes
% of
total
Modified Fisher exact
P value
Bonferroni-adjusted
P value
2.3 8.7 1013 2.3  109
2.3 1.4  1012 3.6  109
2.0 1.5  1011 3.9  108
2.3 3.5  109 9.4  106
4.5 1.6  107 4.3  104
3.7 9.4  107 2.5  103
6.8 6.8  106 1.8  102
nctional annotation analysis was performed using a list of differentially
with the Agilent mouse microarray G4121A probe list serving as the
.. of
nes
17
17
15
17
33
27
50
VID) fuassociated with the functional term protease (Figure 5A).
s with a
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AJP April 2012, Vol. 180, No. 4The microarray data revealed increased expression of
several metalloproteinases, including MMP-9 (type IV
collagenase, gelatinase), MMP-12 (macrophage elas-
tase), and MMP-14 (membrane type 1–MMP), a protease
critical for MMP maturation. Expression of cathepsins B,
Table 4. Functional Analysis for Biological Function of Genes w
Term
Fo
enrich
Immune system process 4
Immune response 6
Defense response 5
Response to wounding 5
Inflammatory response 6
Response to external stimulus 4
Cell activation 5
Antigen processing and presentation 10
Response to stimulus 1
Leukocyte activation 4
Taxis 7
Regulation of immune response 7
Chemotaxis 7
Regulation of immune system process 7
Positive regulation of immune response 7
Positive regulation of immune system process 7
Locomotory behavior 4
Humoral immune response 9
Adaptive immune response based on somatic
recombination of immune receptors built from Ig
superfamily domains
7
Adaptive immune response 7
Positive regulation of multicellular organismal
process
5
Antigen processing and presentation of exogenous
peptide antigen
18
Activation of immune response 7
Behavior 3
Lymphocyte activation 4
Regulation of multicellular organismal process 3
B-cell–mediated immunity 7
Response to stress 2
Myeloid leukocyte activation 12
Antigen processing and presentation of exogenous
antigen
14
Immune effector process 5
Antigen processing and presentation of peptide
antigen via MHC class II
18
Antigen processing and presentation of exogenous
peptide antigen via MHC class II
18
Antigen processing and presentation of peptide
antigen
11
Antigen processing and presentation of peptide or
polysaccharide antigen via MHC class II
17
Ig-mediated immune response 7
Leukocyte-mediated immunity 5
Hemopoietic or lymphoid organ development 3
Mast cell activation 19
Lymphocyte-mediated immunity 5
Immune system development 3
Immune response–regulating cell surface receptor
signaling pathway
9
Positive regulation of endocytosis 11
B-cell activation 5
Acute inflammatory response 5
Immune response–regulating signal transduction 8
Database for Annotation, Visualization and Integrated Discovery (DA
expressed genes with higher lung expression in SP-C/TNF- mice (47
microarray G4121A probe list served as the background. Enriched term
MHC, major histocompatibility complex.D, K, S, and Z was also increased, as were genes in-volved in pro-inflammatory caspase activity (caspases 1,
4, and 11 and CARD12). Real-time PCR conducted on
independent biological samples confirmed significantly
increased expression of MMPs (MMPs 2, 9, 12, and 14;
P  0.05; Figure 5B). In contrast, expression of the MMP
her Lung Expression in SP-C/TNF- Mice
No. of
genes
% of
total
Modified Fisher
exact P value
Bonferroni-adjusted
P value
92 20.6 6.2  1039 3.2  1035
72 16.1 7.2  1037 3.7  1033
57 12.8 5.2  1024 2.7  1020
44 9.9 1.4  1019 7.3  1016
37 8.3 9.5  1019 4.9  1015
53 11.9 9.8  1019 5.1  1015
32 7.2 2.9  1013 1.5  109
18 4.0 9.4  1013 4.9  109
120 26.9 1.0  1012 5.2  109
29 6.5 9.2  1012 4.7  108
21 4.7 1.1  1011 5.6  108
21 4.7 1.1  1011 5.6  108
21 4.7 1.1  1011 5.6  108
21 4.7 1.5  1011 7.8  108
19 4.3 6.4  1011 3.3  107
19 4.3 9.1  1011 4.7  107
26 5.8 1.2  1010 6.3  107
15 3.4 2.1  1010 1.1  106
18 4.0 4.7  1010 2.4  106
18 4.0 4.7  1010 2.4  106
19 4.3 4.9  109 2.5  105
9 2.0 1.1  108 5.6  105
15 3.4 1.3  108 6.4  105
29 6.5 2.0  108 1.0  104
23 5.2 3.3  108 1.7  104
28 6.3 4.5  108 2.3  104
14 3.1 4.7  108 2.4  104
49 11.0 4.8  108 2.5  104
10 2.2 5.7  108 2.9  104
9 2.0 9.5  108 4.9  104
18 4.0 9.8  108 5.0  104
8 1.8 1.1  107 5.8  104
8 1.8 1.1  107 5.8  104
10 2.2 1.4  107 7.1  104
8 1.8 1.8  107 9.3  104
13 2.9 2.8  107 1.4  103
15 3.4 3.1  107 1.6  103
24 5.4 4.8  107 2.4  103
7 1.6 7.2  107 3.7  103
14 3.1 9.5  107 4.9  103
24 5.4 1.5  106 7.6  103
9 2.0 3.0  106 1.5  102
8 1.8 3.1  106 1.6  102
13 2.9 5.3  106 2.7  102
12 2.7 7.1  106 3.6  102
9 2.0 8.4  106 4.2  102
nctional annotation analysis was performed using a list of differentially
es and 446 unique DAVID identification numbers). The Agilent mouse
Bonferroni-adjusted P  0.05 are displayed.ith Hig
ld
ment
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AJP April 2012, Vol. 180, No. 4kazal motifs, TIMP-2, and TIMP-3) and the predicted
MMP inhibitor procollagen C-terminal enhancer protein
2a were all significantly decreased (P 0.05, Figure 5C).
Compared with the marked decrease in TIMP-3 expres-
sion in the transgenic animals, there was less of an im-
pact on TIMP-2 mRNA levels (P  0.05) and no signifi-
cant change in TIMP-1 expression (P  0.05). Differential
expression of cathepsin K, caspases 1 and 4, and
CARD12 was also verified by real-time PCR (P  0.05,
Figure 5D).
Expression of Genes Involved in Lung Repair
and Maintenance
Given the importance of repair and maintenance pro-
cesses in the control of lung architecture integrity, and in
the fate of lungs after injury, we examined expression of
genes associated with the terms angiogenesis, cytoskel-
eton organization, and biogenesis (Figure 6). Most genes
associated with these terms exhibited decreased expres-
sion in SP-C/TNF- mice. Factors implicated in endothe-
lial cell survival and proliferation, including vascular en-
dothelial growth factor (VEGF) and one of its receptors,
FMS-like tyrosine kinase-1 (VEGF receptor-1), connec-
tive tissue growth factor, c-fos–induced growth factor
(VEGFD), heparin-binding EGF-like growth factor, en-
doglin, and the transcription factor inhibitor of DNA bind-
ing 1 all exhibited decreased expression compared with
wild-type littermates (Figure 6A). The expression of
smooth muscle transcripts associated with myofibro-
blasts was also predominantly decreased, including cal-
ponin, myosin, troponin, tubulin, and gelsolin, a potent
actin filament regulatory protein involved in the mainte-
nance of lung vascular barrier function26 (Figure 6B).
TGF-, a factor implicated in the pathogenesis of fibrosis
and in conversion of fibroblasts to myofibroblasts, exhib-
ited a modest increase. However, expression of a down-
stream mediator involved in myofibroblast differentiation
and stimulation of fibroblast matrix production,27 connec-
tive tissue growth factor, was significantly decreased.
Real-time PCR performed on independent biological
samples confirmed differential expression of TGF-, con-
Table 5. Functional Analysis for Biological Function of Genes w
Term
Fol
enrichm
Anatomical structure development 2
Organ development 2.3
Enzyme-linked receptor protein signaling pathway 4.5
System development 2.1
Cytoskeleton organization and biogenesis 3.2
Blood vessel morphogenesis 4.9
Blood vessel development 4.6
Anatomical structure morphogenesis 2.2
Vasculature development 4.5
Organ morphogenesis 3
Database for Annotation, Visualization and Integrated Discovery (DA
expressed genes with lower lung expression in SP-C/TNF- mice (28
microarray G4121A probe list served as the background. Enriched termnective tissue growth factor, and VEGF and decreasedexpression of lysyl oxidase, a factor critical for elastin
cross-linking28 (Figure 6C).
Comparison of SP-C/TNF- Lung
Transcriptome and Other Models of
Lung Disease
To gain further insight into the relative importance of
differentially expressed genes in defining the phenotype
of transgenic animals, data from the present study were
compared with 12 other mouse models of lung disease.7
These included a model of IL-13 overexpression, two
models of bleomycin-induced injury (9 and 21 days after
treatment), two models of lipopolysaccharide exposure
(inhalation and i.p. injection), two allergy models involv-
ing challenge with ovalbumin, and five models of bacte-
rial infection. Of the 7148 genes common to all platforms
used in these studies, 736 were differentially expressed
(FDR-adjusted P 0.05 and1.5-fold change in expres-
sion) in the SP-C/TNF- model. Unsupervised clustering
of the expression profiles generated using the top 50
differentially expressed genes, according to fold change
from each model, showed that the SP-C/TNF- model
clustered with the two bleomycin models (Figure 7). Sim-
ilar clusters were seen using the top 25 or 100 differen-
tially expressed genes (data not shown), indicating that
the relationships among models were fairly robust. Given
that bleomycin treatment leads to fibrosis, comparison of
differentially expressed genes common to the SP-C/
TNF- model or unique to the bleomycin models might
serve to identify processes critical for disease pathogen-
esis. Functional assessment of differentially expressed
genes with1.5-fold change common to the SP-C/TNF-
model and either the 9- or the 21-day bleomycin model
revealed enrichment of genes involved in inflammation/
immune response. Similar pathways were found for all
comparisons of models with SP-C/TNF- mice (Table 7),
suggesting that these processes constitute common
features of lung disease. Indeed, of the 23 transcripts
found to be differentially expressed in common across
most (at least 9 of 12) models7 and present on the array
used in the present study, 19 were similarly altered in
er Lung Expression in SP-C/TNF- Mice
No. of
genes
% of
total
Modified Fisher
exact P value
Bonferroni-adjusted
P value
57 19.9 1.2  107 6.1  104
45 15.7 1.4  107 7.1  104
19 6.6 2.3  107 1.2  103
50 17.4 4.7  107 2.4  103
22 7.7 4.6  106 2.3  102
14 4.9 5.1  106 2.6  102
15 5.2 5.1  106 2.6  102
37 12.9 5.1  106 2.6  102
15 5.2 5.9  106 3.0  102
23 8.0 6.4  106 3.3  102
nctional annotation analysis was performed using a list of differentially
s and 287 unique DAVID identification numbers). The Agilent mouse
Bonferroni-adjusted P  0.05 are displayed.ith Low
d
ent
VID) fuSP-C/TNF- mice (see Supplemental Table S2 at http://
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AJP April 2012, Vol. 180, No. 4ajp.amjpathol.org).7 Genes differentially expressed in the
bleomycin models, but not the SP-C/TNF- model, were
enriched for extracellular matrix genes, including in-
creased expression of collagens, elastin, and fibronectin
transcripts. Connective tissue growth factor mRNA was
elevated in the 21-day bleomycin model of fibrosis (1.7-
fold) and not in any other model. Functional assessment
of genes differentially expressed in other models did not
reveal similar enrichment for extracellular matrix genes
(Table 7), indicating that this difference was specific to
the bleomycin models.
To identify genes unique to the SP-C/TNF- model,
genes were selected that were differentially expressed in
Table 6. Clustering of Functional Groups
Functional cluster
Group
P value
No. of
genes
Glycoprotein/extracellular space 3.2 1021 319
Immune/inflammatory response 1.1 1016 165
Lysosome 5.6  1010 31
Ig-like 1.6  109 60
Ig C1 set 4.8  109 28
Chemokine activity 1.4  108 98
Membrane 7.7  107 325
Ig 1.3  105 22
Carbohydrate binding 4.6  105 34
Antigen processing and
presentation
7.0  105 28
Hemopoietic or lymphoid organ
development
1.4  104 29
Immune/inflammatory response 2.7 104 76
Carbohydrate-binding/C-type
lectin
2.8  104 33
Small chemokine 4.4  104 8
Ig C region 1.2  103 7
Proteases/peptidases and
inhibitors
2.2  103 48
Plasma membrane part 2.5  103 90
Immune and inflammatory
signaling pathway
5.5  103 10
Lymphocyte proliferation and
activation
5.5  103 52
Cell differentiation/organ
development
6.7  103 178
Cell adhesion 7.7 103 39
Phagocytosis 9.2  103 41
TNF 9.6  103 7
Blood coagulation 1.1  102 11
Oxidoreductase activity 1.3  102 9
Cell membrane 1.5  102 499
Myeloid leukocyte differentiation 1.6 102 8
Protease inhibitor 1.9  102 31
Angiogenesis 2.3  102 45
Leukocyte migration 2.7  102 7
Cell proliferation 3.1  102 33
SH2 domain 3.3  102 11
Lipid binding 3.3  102 24
Integrin complex 4.5  102 24
Cystine knot, C terminal 4.5  102 4
Chemokine receptor activity 4.7 102 15
Database for Annotation, Visualization and Integrated Discovery
(DAVID) functional annotation clustering analysis was performed using a
list of differentially expressed genes (760 probes and 732 unique DAVID
identification numbers) with the Agilent mouse microarray G4121A probe
list serving as the background. The group P value is the geometric mean
of all modified Fisher exact P values in a given annotation cluster. Func-
tional groups clustered using medium stringency with a modified Fisher
exact P  0.05 are displayed.SP-C/TNF-mice (FDR-adjusted P 0.05 and twofold orgreater change in expression) and not differentially ex-
pressed (unadjusted P  0.05 or 1.5-fold change in
expression) in any other model. This relatively stringent
approach identified 29 genes (Table 8). Functional as-
sessment did not detect any significant enrichment of
gene terms, and broadening the list to include unique
genes with1.5-fold change in gene expression (n 80)
did not significantly alter results (data not shown). A
PubMed search for each gene and the term emphysema
identified three of the top eight genes, ranked by fold
change, as having previously been linked to the disease.
These genes were triggering receptor expressed on my-
eloid cells 2 (13.1-fold), transcription factor Spi-C (5.3-
fold), and caspase-1 (3.1-fold). Also included in the top
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Figure 4. Inflammatory mediators. A: Heat map of differentially expressed
genes with the functional annotation inflammatory response. Red indicates a
high level of expression relative to the reference RNA, whereas green indi-
cates low relative expression. B: Real-time PCR was conducted on indepen-
dent biological samples from age-matched animals (n  4 per genotype) to
verify microarray results. LTa, lymphotoxin A; SAA3, serum amyloid A3; WT,
wild type. *P  0.05, t-test.
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AJP April 2012, Vol. 180, No. 410 genes were the TNF receptor superfamily member 17
(3.5-fold) and the aryl hydrocarbon receptor repressor
(3.0-fold), consistent with TNF- signaling and repression
of the aryl hydrocarbon receptor pathway, respectively.
Discussion
Depending on the context, TNF- expression can elicit a
variety of biological responses, including provoking the
influx of inflammatory cells, exerting an effect on resident
cells, and increasing production of proteolytic factors;
cell death, proliferation, and migration may also occur.
Although it remains unclear to what extent TNF- is im-
plicated in the development of emphysema in humans,
TNF-null mice exhibit significantly reduced inflammation
and airspace enlargement in response to 6 months of
exposure to cigarette smoke,8 suggesting an important
role in disease pathogenesis. The dominant feature of the
lung transcriptome of TNF-overexpressing mice was in-
creased expression of genes involved in immune and
inflammatory processes, consistent with the pro-inflam-
matory role of TNF- and with the pronounced inflamma-
tion evident in the lungs. In a conditional TNF-overexpres-
sion model, only mild inflammatory changes were
observed and TNF- mRNA was itself not detected29; in
the present model, TNF-mRNA levels were several hun-
dredfold higher according to real-time PCR analysis as a
result of the constitutive expression of the TNF- trans-
gene. The robust inflammatory response observed in the
lungs and bronchoalveolar lavage fluid were reflected in
the enrichment of genes that play a role in inflammation.
Chemokines, critical for the influx of lymphocytes in the
Alungs, were highly expressed, as were transcripts knownto be expressed by lymphocytes. Also increased were
genes involved in the processing of cytokines to their
mature forms, including inflammatory caspases with
known pro-inflammatory roles.30 Lungs of transgenic
mice also exhibited decreased expression of genes in-
volved in xenobiotic metabolism, consistent with known
effects of inflammation on the aryl hydrocarbon receptor
signaling pathway31; tight junction and adhesion factors,
consistent with alteration of lung barrier function by TNF-
32; and glutathione metabolism, consistent with impacts of
inflammation on antioxidant status.33
The degradation of alveolar wall structure in emphy-
sema is thought to be due, in large part, to protease/anti-
protease imbalance, exemplified by increased levels and
activity of proteases, such as MMPs; increased expres-
sion of factors that enhance protease expression and
activity; and decreased levels of inhibitors. The functional
significance of protease/anti-protease imbalance is dem-
onstrated in several animal models. MMP-12/ mice are
protected from emphysema, resulting from long-term ex-
posure to cigarette smoke34; and airspace enlargement
in mice, resulting from overexpression of IL-13 in the
airways, is abrogated somewhat by inhibition or knockout
of MMP-9 or MMP-12.35 TIMP-3/ mice, but not TIMP-
1/ or TIMP-2/ mice, exhibit airspace enlargement
characteristic of pulmonary emphysema.36 Functions of
MMPs and their inhibitors extend beyond matrix remod-
eling, with several MMPs capable of processing pro-TNF
to the active form,37 whereas TIMP-3 can inhibit the TNF-
converting enzyme38 and, thus, serve as an important
regulator of inflammation. Our data indicate that TNF-
overexpression leads to profound disruption at several
TIMP-1 TIMP-2 TIMP-3 RECKPCOLCE2
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Figure 5. Proteases and anti-proteases. A: Heat map depicting microarray
data of differentially expressed genes with the functional annotation pro-
tease. Red indicates a high level of expression relative to the reference RNA,
whereas green indicates low relative expression. B–D: Real-time PCR was
used to examine relative expression levels in independent biological samples
from age-matched animals (n  4 per genotype). B: MMP expression. MT,
membrane type. C: Inhibitors of MMPs. PCOLCE2, procollagen C–endopep-
tidase enhancer 2; RECK, reversion-inducing cysteine-rich protein with kazal
motifs. NS, not significant; WT, wild type. D: Selected additional proteases.
CARD, caspase-associated recruitment domain; CASP, caspase; CTSK, ca-
thepsin K. *P  0.05, t-test.levels of protease regulation. Serum amyloid A3, which
el of ex
F, conn
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AJP April 2012, Vol. 180, No. 4was among the most increased transcripts, is a TNF-
responsive39 acute-phase response factor that can reg-
ulate MMP activity.40 Transgenic animals displayed in-
creased transcription of MMPs 2, 9, and 12, each of
which cleaves basement membrane proteins, including
elastin, and increased expression of membrane type
1–MMP, a transmembrane MMP critical for the activation
of pro-MMP forms. Increased cathepsin expression is
consistent with their role in matrix remodeling in the
lungs.41 In contrast, metalloproteinase inhibitors (rever-
sion-inducing cysteine-rich protein with kazal motifs,
TIMP-2, and TIMP-3) exhibited decreased expression rel-
ative to levels in the lungs of wild-type animals. Procolla-
gen C-terminal enhancer protein 2a, a protein antagonis-
tic to metalloproteases that provokes a net increase in
deposition of fibrous matrix,42–44 was the transcript most
decreased in transgenic animals. Thus, genes with the
greatest differential expression in this model are regula-
tors of MMP activity. Overall, there was a clear shift at the
transcriptional level in the protease/anti-protease bal-
ance toward increased proteolytic activity.
Although the protease/anti-protease hypothesis has
been the dominant view of emphysema pathogenesis,
impacts of vascular abnormalities have also been con-
sidered.45 VEGF is required for endothelial cell survival,
and decreased signaling through its receptors is associ-
ated with apoptosis and airspace enlargement,5 sug-
gesting that capillary endothelial cells are required for
A B
Figure 6. Repair and maintenance. Heat maps were generated depicting micro
(A) or cytoskeleton organization and biogenesis (B). Red indicates a high lev
expression. C: Expression of select genes was confirmed by real-time PCR. CTGmaintenance of alveolar structure. Reduced VEGF ex-pression was previously observed in the SP-C/TNF-
model and was associated with pulmonary hypertension
at altitude in Denver, CO,46 although the effects on both
VEGF expression and hypertension were attenuated at
sea level in Japan without any reduction in the emphy-
sema.47 Herein, we extend this observation by showing
that transcript levels of several genes involved in angio-
genesis are lower in the transgenic mice, suggesting that
dysfunction of blood vessel development is a feature of
the SP-C/TNF- model, as is seen in emphysema in hu-
man lungs.45 Decreased expression of the transcription
factor inhibitor of DNA binding 1, an endothelial progen-
itor cell marker that regulates angiogenesis, may be an
important driver of these effects.48 Pulmonary hyperten-
sion is often detected in patients with emphysema and is
thought to be mainly due to hypoxia, inflammation, and
loss of capillaries.49 Although pulmonary hypertension
was not assessed in the present work, the observation of
decreased expression of VEGF and genes involved in
angiogenesis in our laboratory in Ottawa, ON, Canada
(approximately 70 m above sea level), suggests that ef-
fects on this system may not be strictly dependent on
altitude.
Although the SP-C/TNF- mouse was initially pro-
posed as a model of pulmonary fibrosis,11 4-month-old
mice were resistant to the development of fibrosis after
treatment with the profibrotic agent bleomycin or TGF-
.17 The presence of functional repair mechanisms is a
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ta of differentially expressed genes with the functional annotation angiogenesis
pression relative to the reference RNA, whereas green indicates low relative
ective tissue growth factor; LOX, lysyl oxidase; WT, wild type. *P  0.05, t-test.array dacritical determinant of lung fate after injury, with connec-
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AJP April 2012, Vol. 180, No. 4tive tissue synthesis during the healing process a prereq-
uisite for fibrosis.50 Myofibroblasts are the primary cell
type responsible for connective tissue synthesis during
repair processes, and although they play a central role in
the pathogenesis of fibrosis,27 there is evidence of dis-
ruption of myofibroblast structure and function in emphy-
sema.51 Despite a modest increase of TGF- mRNA in
SP-C/TNF- animals, we observed decreased expres-
sion of connective tissue growth factor, an important
downstream mediator of TGF-–regulated myofibroblast
differentiation and extracellular matrix production,27 and
lower expression of genes involved in cytoskeleton orga-
nization, biogenesis, and myofibroblast differentiation.
TNF- can down-regulate connective tissue growth fac-
tor52 and antagonize TGF-–driven myofibroblast differ-
entiation,53 which may provide a critical break in the
TGF- signaling required for fibrosis. The transcriptional
changes suggest a pulmonary environment resistant to
myofibroblast differentiation and are in sharp contrast
with the up-regulation of smooth muscle–related tran-
scripts observed after treatment of fibroblasts with TGF-
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ct.54 Although fibroblast proliferation was reported in theinitial characterization of the SP-C/TNF- mouse, the
cells were negative by immunocytochemistry to anti-
smooth muscle actin- antibody,11 a myofibroblast
marker. The physiological significance of decreased
myofibroblast-associated gene expression in determin-
ing lung fate is substantiated in other animal models. For
example, expression of gelsolin is required for the devel-
opment of pulmonary fibrosis in bleomycin-treated
mice,55 whereas inhibition of lysyl oxidase in guinea pigs
exposed to CdCl2 resulted in emphysema, rather than the
fibrotic phenotype observed in the presence of lysyl ox-
idase.50 Together, the data describe a pulmonary envi-
ronment characterized by transcriptional changes asso-
ciated with emphysema, coupled with transcriptional
changes that suggest resistance to fibrosis, consistent
with the phenotype described herein and elsewhere.17
Analysis of whole lung homogenates provides a global
view of transcriptional changes in the lungs but may
be insensitive to contributions from specific cell types
or lung regions. Despite the dramatic transcriptional
changes presented herein, another level of complexity is
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Figure 7. Comparison of multiple lung disease
models. Lung disease models were compared by
hierarchical clustering according to the most dif-
ferentially expressed transcripts for each model.
Transcripts with unadjusted P  0.05 were
ranked by fold change, and the top 50 transcripts
for each disease model were selected, resulting
in 331 unique transcripts used for clustering.
LPS, lipopolysaccharide; M. pulmonis, Myco-
plasma pulmonis; M. tuberculosis, Mycobacte-
rium tuberculosis; N. brasiliensis, Nippostrongy-
lus brasiliensis; OVA, ovalbumin; P. aeruginosa,
Pseudomonas aeruginosa.TN
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Maintenance of alveolar architecture depends on the in-
tegrity of the scaffold and cellular relationships. After
injury, successful lung repair relies on complex interac-
tions of type II epithelial cells, fibroblasts, endothelial
cells, and connective tissue governed by growth factors
and cytokines, as well as by direct cell-cell and cell-
matrix contacts. The high level of TNF- produced by
type II cells may interfere with the local cellularity and
architectural integrity that guide epithelial and fibroblast
proliferation and differentiation51,56 and, thus, contribute
to remodeling and loss of alveolar structure. As in any
analysis of whole tissues, transcript levels will be influ-
enced by changes in cell composition in addition to strict
transcriptional activation. For example, we observed in-
creased levels of Ig genes, consistent with the infiltration
of B cells into the lungs. Nevertheless, the abundant
changes in gene expression measured herein, whether
from transcriptional activation or through import by in-
flammatory cells, reflect ongoing processes in the lungs
that contribute to the observed pathological features and,
therefore, are useful in understanding the underlying
causes of disease.
Comparison across multiple models of lung disease
using global screening approaches can be used to iden-
tify gene profiles that distinguish disease phenotypes.
We analyzed similarities and differences between the
Table 7. Functional Comparison of Gene Profiles across Mouse
Model Functional analysis of comm
Bleomycin
Acute (7 days) Glycoprotein, immune/inflamma
(n  53)
Fibrosis (21 days) Glycoprotein, lysosome, chemo
chemotaxis (n  119)
Aspergillus extract Glycoprotein, inflammatory resp
chemotaxis (n  29)
Nippostrongylus brasiliensis Glycoprotein, immune/inflamma
lysosome (n  193)
IL-13 overexpression Glycoprotein, lysosome, immun
response (n  207)
Ovalbumin
BALBc Glycoprotein, immune/inflamma
chemokine (n  319)
C57BL6 Glycoprotein, inflammatory resp
chemokine (n  182)
LPS
Aerosolized Glycoprotein, immune/inflamma
chemokine (n  158)
i.p. Immune/inflammatory response
peptide, small chemokine (n
Mycoplasma pulmonis Glycoprotein, immune response
(n 358)
Mycobacterium tuberculosis Immune/inflammatory response
lysosome (n  304)
Pseudomonas aeruginosa Glycoprotein, immune/inflamma
regulation of cytokine produc
Common genes were defined as being differentially expressed by at lea
(unadjusted P  0.05). Unique or discordant (expressed in both models,
group. Functional terms listed represent the most enriched clusters
Visualization and Integrated Discovery. The 7148 GenBank identification
population for enrichment analysis.
*The number in common is given in parentheses.
†The number unique or discordant is given in parentheses.
LPS, lipopolysaccharide.SP-C/TNF- mice and 12 models of lung disease previ-ously analyzed by gene expression profiling.7 This rich
data set of transcriptomes provides an ideal resource
because of the breadth of pulmonary disease processes
covered, encompassing models of acute lung injury, al-
lergic inflammation, and bacterial infection, and also be-
cause many of the models share the same genetic back-
ground as the SP-C/TNF- model (C57BL/6). The small
set of genes uniquely altered in the SP-C/TNF- model is
likely enriched for genes involved in disease pathogen-
esis, providing candidates for further study. Indeed, three
of the top eight genes identified have previously been
associated with emphysema, including caspase-1, which
was recently shown to be an important factor in cigarette
smoke–induced emphysema through its role as an IL-1–
converting enzyme57; Spi-C, a transcription factor impli-
cated in transcriptional activation of MMP-12 previously
identified in an emphysema model58; and triggering re-
ceptor expressed on myeloid cells 2, a factor critical for
macrophage migration found to be increased in former
smokers with chronic obstructive pulmonary disease.59
Remarkably, the SP-C/TNF- model clustered most
closely with two disease models representing responses
to the profibrotic agent, bleomycin, used to model acute
lung injury (7 days after exposure) or fibrosis (21 days
after exposure). Functional analysis of genes common to
SP-C/TNF- and bleomycin models indicated that the
similarity was due primarily to the inflammatory/immune
of Lung Disease
nes* Functional analysis of unique genes†
sponse Extracellular matrix, collagen (n  126)
Glycoprotein, cell adhesion, extracellular matrix,
collagen (n  232)
Thyroglobulin type-1, heat shock protein 70, lipid
transport (n  146)
sponse, Inflammatory response, glycoprotein, cell
adhesion (n  467)
matory Glycoprotein, inflammatory response, chemotaxis
(n  441)
sponse, DNA replication, purine ribonucleotide-binding,
chromatin modification (n  736)
Inflammatory response, glycoprotein, acute
phase response (n  307)
sponse, Basic leucine zipper, protein dimerization activity,
toll-like receptor signaling (n  748)
l
)
Basic leucine zipper, wound healing, lysosome
(n  1208)
okine Wound healing, glycoprotein, glycolysis
(n  957)
protein, Cytoskeleton organization, Golgi apparatus,
hypertrophic cardiomyopathy (n  845)
sponse,
 159)
Protein dimerization, basic leucine zipper, GTP
binding (n  738)
old in both SP-C/TNF- (FDR-adjusted P 0.05) and each disease model
reased in one and decreased in the other) genes composed the second
functional annotation clustering using the Database for Annotation,
s common to all platforms under comparison were used as the referenceModels
on ge
tory re
kine,
onse,
tory re
e/inflam
tory re
onse,
tory re
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 229
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tory re
tion (n
st 1.5-f
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numberresponse common to the models, processes observed
-fold ch
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AJP April 2012, Vol. 180, No. 4across all lung models that likely play a role in common
features of disease pathogenesis. However, the gene
expression profiles of the bleomycin models showed en-
richment of genes involved in production and deposition
of extracellular matrix, a key feature of fibrosis not present
in the SP-C/TNF- model. Connective tissue synthesis
appears to be important in determining lung fate after
injury,50 and induction of connective tissue growth factor
is required for the development of lung fibrosis.60 Be-
cause SP-C/TNF- mice exhibit decreased expression
of genes implicated in myofibroblast differentiation and
extracellular matrix production, including connective
tissue growth factor, it seems plausible that the resis-
tance to induction of fibrosis is due at least in part to an
inability of bleomycin or TGF- to elicit significant syn-
thesis and deposition of extracellular matrix in these
animals. The data suggest that this impaired repair
process is an important feature distinguishing the SP-
C/TNF- model from the bleomycin models of acute
lung injury and fibrosis.
The dysfunctional immune processes, imbalance of
proteases and their inhibitors, and disruption of mainte-
nance and repair systems revealed by the gene expres-
sion profile of mice overexpressing TNF- may all con-
tribute to the pathogenesis of emphysema.3,6 Although
direct testing of the relative importance of each observed
change was beyond the scope of this work, the litera-
ture5,34–36,50,55,61–64 provides ample evidence of the im-
Table 8. Gene Expression Changes Unique to the SP-C/TNF- M
GenBank no. Gene symbol
NM_031254 Trem2 Triggeri
AK008551 2010309G21Rik RIKEN
NM_011461 Spic Spi-C tr
NM_007793 Cstb Cystatin
NM_011608 Tnfrsf17 TNF rec
NM_021319 Pglyrp2 Peptido
NM_009267 Spt1 Salivary
NM_009807 Casp1 Caspas
NM_009644 Ahrr Aryl-hyd
NM_013546 Hebp1 Heme-b
NM_024177 Mrpl38 Mitocho
NM_008509 Lpl Lipopro
NM_023383 Aadac Aryl ace
NM_013533 Gpr162 G-prote
NM_009518 Wnt10a Wingles
NM_008964 Ptger2 Prostag
AK014074 Katnal2 Katanin
NM_015775 Tmprss2 Transm
NM_013569 Kcnh2 Potassiu
(eag
NM_054074 Defb6 Defensi
NM_013593 Mb Myoglo
NM_021447 Trim54 Tripartit
NM_011902 Tekt2 Tektin 2
NM_026136 4930449I24Rik RIKEN
NM_007775 Crygc Crystall
AK016963 Dydc2 DPY30
NM_008664 Myom2 Myome
NM_011449 Spa17 Sperm
NM_011569 Tekt1 Tektin 1
Genes were screened for inclusion according to the following criteria:
P  0.05) in the SP-C/TNF- model and not differentially expressed (1.5
models.pact of disruption or overexpression of several genesidentified in the present study (Table 9). Although manip-
ulation of individual genes has provided insight into their
roles in responding to exogenous stimuli or in lung main-
tenance and repair, it is clear that a better understanding
of how these diverse players interact as a system is
needed. This is particularly true in understanding disease
states because effective treatment may require a thera-
peutic approach that targets multiple processes. Our
data indicate that the emphysema phenotype exhibited
by the transgenic SP-C/TNF- mice is characterized by
effects on several pathways (Figure 8). It may be that
perturbation of any one of the highly interdependent pro-
cesses that govern alveolar architecture could result in
the emphysema phenotype through subsequent impacts
on all or a subset of these pathways. Application of sys-
tems biology approaches to ascertain to what extent this
is true in other models of emphysema should prove useful
in defining the range and specificity of biological pro-
cesses that play a causal role in disease pathogenesis.
Interspecies comparisons of specific genes implicated
in disease processes are complicated by several factors,
including the possibility that gene products may serve
different functions. A more robust approach compares bi-
ological processes, because these may be more con-
served across species. Gene expression profiling con-
ducted in human lung tissue distinguished between severe
emphysema and mild or no emphysema, through detection
of increased expression of genes involved in oxidative
Gene description Fold change
eptor expressed on myeloid cells 2 13.1
2010309G21 gene 9.5
tion factor (Spi-1/PU.1 related) 5.3
3.7
superfamily, member 17 3.5
recognition protein 2 3.5
n 1 3.2
3.1
on receptor repressor 3.0
protein 1 2.9
ribosomal protein L38 2.4
ase 2.3
deacetylase (esterase) 2.3
pled receptor 162 2.2
ed MMTV integration site 10a 2.1
E receptor 2 (subtype EP2) 2.1
ubunit A-like 2 2.0
e protease, serine 2 2.0
age-gated channel, subfamily H
), member 2
2.1
2.1
2.1
-containing 54 2.2
2.2
4930449I24 gene 2.2
2.3
-containing 2 2.3
2.4
tigenic protein 17 2.5
2.6
ant differential expression (twofold change or greater and FDR-adjusted
ange or greater and unadjusted P  0.05) in any of the 12 lung diseaseodel
ng rec
cDNA
anscrip
B
eptor
glycan
protei
e 1
rocarb
inding
ndrial
tein lip
tamide
in–cou
s-relat
landin
p60 s
embran
m volt
related
n 6
bin
e motif
cDNA
in,  C
domain
sin 2
autoan
significstress, inflammation, and matrix remodeling, and de-
ray data
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consistent with the profiles observed in the SP-C/TNF-
transgenic mice. Nevertheless, there is some evidence
supporting involvement of specific genes in emphysema.
Patients with chronic obstructive pulmonary disorder ex-
hibit high levels of TNF- in the lungs,66 and knockout of
TNF receptors in mice affords some protection from cig-
arette smoke–induced emphysema.8 Emphysematous
lungs exhibit increased MMP-2, MMP-9, MMP-12, and
membrane type 1–MMP.67,68 In animal models, knockout
of MMP-9 or MMP-12 reduces the airspace enlargement
resulting from IL-13 overexpression,35 knockout of
MMP-12 protects against cigarette smoke–induced em-
physema,34 and knockout of TIMP-3 produces emphy-
sema.36 Lower levels of VEGF have been measured in
human emphysematous lungs,69 and inhibition of VEGF
receptors in rats leads to airspace enlargement through
endothelial and epithelial apoptosis.5 It is possible that
emphysematous changes in the lungs are the result of
interactions and combined actions of several pathways.
Similarly, the observed resistance to acute treatment with
Table 9. Functional Analysis of Select Genes Altered in SP-C/TN
Gene
Accession
no.
Expression in
SP-C/TNF mouse*
MMP-9 NM_013599 4.0 (12.4) IL
MMP-12 NM_008605 3.8 (36.4) K
IL
TIMP-3 NM_011595 2.2 (5.2) K
VEGF NM_009505 2.9 (3.2) C
Flt-1 NM_010228 3.7 In
Lox NM_010728 3.3 (5.7) In
K
Gsn NM_146120 2.4 R
Ctgf NM_010217 1.6 (2.5) O
K
*Expression is represented by the fold change, according to microar
TNF-α
Influx of inflammatory cells
Protease production/activation 
(e.g. ↓MMPs, cathepsins, inflammatory 
caspases)
Disruption of endothelial 
maintenance functions 
(e.g. ↓VEGF, Flt-1, Id1)
Alveolar wall 
damage
Reduced expression 
of anti-proteases 
(e.g. ↓TIMPs, RECK)
Tight junction alteration
(e.g. ↓       claudins)
Apoptosis
Inflammatory signal 
production/activation
(e.g. ↓SAA, LTA, chemokines) 
Impaired repair
Processing of 
proTNF-α
Reduced crosslin
extracellular matr
(e.g. ↓lysyl oxidase, PCEmphysemafibrotic agents17 and retinoic acid rescue70 may well be
the result of several effects that persist as a result of the
constitutive expression of TNF-, including impaired re-
pair and maintenance functions. Involvement of TNF- in
fibrosis is controversial. Bleomycin or silica-induced fi-
brosis can be reverted using TNF- antagonists,71 indi-
cating the critical involvement of TNF- in these experi-
mental models. However, because fibrosis can proceed
in the absence of inflammation, and anti-inflammatory
treatments have not proved effective in treating the hu-
man disease, there has been a shift in the view of fibrosis
as an inflammatory disease to one of disordered wound
healing, with TGF- signaling playing a prominent role.72
Emphysema and fibrosis have been detected in the same
lungs,73 suggesting that common processes initiated by
cigarette smoking or other agents can lead to establish-
ment of traits of both pathological conditions in suscep-
tible individuals. Remarkably, it was recently shown that
the presence of detectable interstitial lung abnormalities
in smokers was inversely associated with the degree of
emphysema.74 It is tempting to speculate that factors
licated in Emphysema and Fibrosis
Model Ref. no.
uced airspace enlargement reduced in the
ce of MMP-9
35
t mice protected from cigarette
–induced emphysema
34
uced airspace enlargement reduced in the
ce of MMP-12
35
t mice develop airspace enlargement 36
nal knockout results in emphysema 61
of VEGF receptors resulted in apoptosis
mphysema
5
of lysyl oxidase resulted in emphysema,
than fibrosis, after CdCl2 treatment
50
t mice cannot cross-link collagen or elastin,
onic lethality, embryonic lungs exhibit
sema
62
for the development of fibrosis after
ycin treatment
55
ression in fibroblasts results in fibrosis 63
t has impaired extracellular matrix deposition 64
. Data from real-time PCR are indicated in parentheses, if available.
 of myofibroblast
tion and 
on
 PDGF, gelsolin)
Figure 8. Simplified schematic of major pathways exhibiting
differential expression in the lungs of mice with constitutive
expression of TNF-. Constitutive overexpression of TNF-
under the control of the SP-C promoter results in chronic lung
inflammation and emphysema. Increased cytokine and chemo-
kine production and tight junction alterations promote the in-
flux of inflammatory cells into the lungs. Increased protease
production and activation, coupled with reduced expression of
protease inhibitors, increases the processing and destruction of
basement membrane proteins and cytokine maturation. The
disruption of repair and maintenance functions of endothelial
cells and fibroblasts contributes to the alveolar wall damage and
impairs the capacity to repair. Together, effects on pathways
critical to the maintenance of lung structure result in airspace
enlargement characteristic of emphysema. CTGF, connective
tissue growth factor; Flt, FMS-like tyrosine kinase (VEGF recep-
tor); Id1, inhibitor of DNA binding 1; LTA, lymphotoxin A;
PCOLCE, procollagen C-endopeptidase enhancer; PDGF, plate-
let-derived growth factor; RECK, reversion-inducing cysteine-F- Imp
-13–ind
absen
nockou
smoke
-13–ind
absen
nockou
onditio
hibition
and e
hibition
rather
nockou
embry
emphy
equired
bleom
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nockouInhibition
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OLCE) rich protein with kazal motifs; SAA, serum amyloid A.
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AJP April 2012, Vol. 180, No. 4driving emphysema may inhibit the development of fibro-
sis, as is implied by the SP-C/TNF- lung transcriptome
analyses or, conversely, that fibrotic changes inhibit em-
physema, in which the local pulmonary environment is
permissive to fibrosis.
In summary, mice with increased expression of TNF-
in type II alveolar epithelial cells exhibit pronounced tran-
scriptional changes in key pathways that control alveolar
wall integrity. We found striking increases in the expres-
sion of genes involved in inflammatory and proteolytic
processes, in line with the pronounced inflammation and
alveolar wall destruction. We also detected decreased
expression of genes involved in anti-protease and repair
and maintenance processes, suggesting that regulatory
systems that control protease activities were impaired as
a result of constitutive expression of TNF-. The de-
creased expression of factors involved in myofibroblast
differentiation, matrix deposition, and cross-linking of
basement membrane proteins may contribute to the loss
of connective tissue scaffolding and to the resistance to
induction of fibrosis observed in this model. Our data
indicate that the resulting pathological condition, al-
though arising from overexpression of a single gene, is
characterized by critical effects on several pathways rel-
evant to the control of alveolar wall homeostasis (Figure
8). Overall, the transcriptional changes correspond well
with the observed phenotype and provide evidence sup-
porting involvement of key genes and pathways in dis-
ease pathogenesis. Understanding the mechanisms that
govern normal and dysfunctional lung responses to injury
has the potential to uncover therapeutic opportunities to
address chronic lung diseases. The present work identi-
fies several key transcriptional changes that can serve as
targets for future assessment using available molecular
biology tools and provides a data set that can be inter-
rogated for hypothesis generation. Comparison of dis-
ease models using transcriptome-wide screening should
prove useful for the identification of genes, pathways,
and processes that warrant further investigation in dis-
eases of unknown cause.
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